Obestatin as contractile mediator of excised frog heart

Central European Journal of Biology

Volumn 4, Issue 3, 2009, Pages 327-334

  Sazdova, Iliyana V ^a   Ilieva, Bilyana M ^a   Minkov, Ignat B ^a   Schubert, Rudolf ^b   Gagov, Hristo S ^a,c  

^a UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c INSTITUTE OF BIOPHYSICS AND BIOMEDICAL ENGINEERING   (Bulgaria)

Author keywords

Autonomic nervous system; Cardiac; G protein; Hormone; In vitro; Obestatin

Indexed keywords

ANURA; RANA RIDIBUNDA;

EID: 70350068411     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-009-0023-3     Document Type: Article

References (27)

1. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., et al., Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake, Science, 2005, 310, 996-999.
2. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa, K., Ghrelin is a growth-hormonereleasing acylated peptide from stomach, Nature, 1999, 402, 656-660.
3. Korbonits M., Bustin S.A., Kojima M., Jordan S., Adams E.F., Lowe D.G., et al., The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors, J. Clin. Endocrinol. Metab., 2001, 86, 881-887.
4. Li A., Cheng G., Zhu GH., Tarnawski A.S., Ghrelin stimulates angiogenesis in human microvascular endothelial cells: Implications beyond GH release, Biochem. Biophys. Res. Commun., 2007, 353, 238-243.
5. Zhang J.V., Jahr H., Luo C.W., Klein C., van Kolen K., Ver Donck L., et al., Obestatin induction of earlyresponse gene expression in gastrointestinal and adipose tissues and the mediatory role of G proteincoupled receptor, GPR39, Mol. Endocrinol., 2008, 22, 1464-1475.
6. Garg A., The ongoing saga of obestatin: is it a hormone?, J. Clin. Endocrinol. Metab., 2007, 92, 3396-3398.
7. Pazos Y., Alvarez C.J., Camina J.P., Casanueva F.F., Stimulation of extracellular signal-regulated kinases and proliferation in the human gastric cancer cells KATO-III by obestatin, Growth Factors, 2007, 25, 373-381.
8. Alvarez C., Lodeiro M., Theodoropoulou M., Camina J., Casanueva F., Pazos Y., Obestatin stimulates Akt signalling in gastric cancer cells through β-arrestinmediated epidermal growth factor receptor transactivation, Endocr. Relat. Cancer, 2009, 16, 599-611.
9. Ivanova I.V., Schubert R., Duridanova D.B., Bolton T.B., Lubomirov L.T., Gagov H.S., Cocaine- and amphetamine-regulated transcript (CART) peptide as an in vivo regulator of cardiac function in Rana ridibunda frog, Exp. Physiol., 2007, 92, 1037-1046.
10. Hartzell H.C., Distribution of muscarinic acetylcholine receptors and presynaptic nerve terminals in amphibian heart, J. Cell Biol., 1980, 86, 6-20.
11. 2+ current in frog ventricular cardiomyocytes by guanosine 5′-triphosphate analogues and isoproterenol, J. Gen. Physiol., 1993, 102, 525-549.
12. 2+ channels and betaadrenoceptors on the sarcolemmal membrane of frog cardiomyocytes, J. Physiol., 1997, 503, 471-477.
13. Nagaya N., Uematsu M., Kojima M., Date Y., Nakazato M., Okumura H., et al., Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors, Circulation, 2001, 104, 2034-2038.
14. Lohse M.J., Engelhardt S., Eschenhagen T., What is the role of beta-adrenergic signaling in heart failure, Circ. Res., 2003, 93, 896-906.
15. 2 subunit of L-type voltage-dependent calcium channels, Biochemistry, 1999, 38, 10361-10370.
16. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., et al., PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts, Cell, 2000, 101, 365-376.
17. Simmerman H.K., Jones L.R., Phospholamban: protein structure, mechanism of action, and role in cardiac function, Physiol. Rev., 1998, 78, 921-947.
18. Sulakhe P.V., Vo X.T., Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli, Mol. Cell. Biochem., 1995, 149-150, 103-126.
19. 2+ transport mechanisms, Pflugers Arch., 1983, 398, 274-283.
20. Fan J., Shuba Y.M., Morad M., Regulation of cardiac sodium-calcium exchanger by β-adrenergic agonists, Proc. Natl. Acad. Sci. USA, 1996, 93, 5527-5532.
21. Zhang Z.Y., Zhou B., Xie L., Modulation of protein kinase signaling by protein phosphatases and inhibitors, Pharmacol. Ther., 2002, 93, 307-317.
22. Kunst G., Kress K.R., Gruen M., Uttenweiler D., Gautel M., Fink R.H., Myosin Binding Protein C, a Phosphorylation-Dependent Force Regulator in Muscle That Controls the Attachment of Myosin Heads by Its Interaction With Myosin S2, Circ. Res., 2000, 86, 51-58.
23. Liu X., Wu W.K.K., Yu L., Li Z.J., Sung J.J.Y., Zhang S.T., et al., Epidermal growth factor-induced esophageal cancer cell proliferation requires transactivation of α-adrenoceptors, J. Pharmacol. Exp. Ther., 2008, 326, 69-75.
24. 2-adrenoreceptor in the frog, Comp. Biochem. Physiol. C, 1978, 60, 165-173.
25. Camina J.P., Campos J.F., Caminos J.E., Dieguez C., Casanueva F.F., Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms, J. Cell Physiol., 2007, 211, 1-9.
26. Ca channels, Peptides, 2006, 27, 1616-1623.
27. Iglesias M.J., Piñeiro R., Blanco M., Gallego R., Diéguez C., Gualillo O., et al., Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes, Cardiovasc. Res., 2004, 62, 481-488.